2022

LimmaTech Enters Exclusive License and Collaboration Agreement with Griffith University to Expand its Vaccine Technology Platform

LimmaTech Biologics will be attending the 2022 VASE Conference in Washington from 29 November through 1 December 2022.

LimmaTech Biologics will be attending the Bactivac Annual Network Meeting 2022 in Kilifi, Kenya from 8 through 10 November 2022.

LimmaTech Biologics will be attending the BIO-EUROPE in Leipzig, Germany from 24 through 26 October 2022.

LimmaTech Biologics will be attending the DCVMN Annual General Meeting 2022 in Pune, India from 20 through 22 October 2022.

LimmaTech Biologics will be attending the World Vaccine Congress Europe 2022 in Barcelona from 11 through 14 October 2022.

LimmaTech Biologics will be attending the 22nd International Pathogenic Neisseria Conference in Cape Town from 9 through 14 October 2022.

LimmaTech Biologics will be attending the 16th Vaccine Congress in Riva del Garda, Italy from 12 through 14 September 2022.

LimmaTech Biologics will be attending the Biennial Meeting on Microbial Carbohydrates in Naples from 27 through 29 July 2022.

LimmaTech Biologics will be attending the Microbial Glycobiology Conference in Lisbon from 12 through 16 June 2022.

LimmaTech Biologics will be attending virtually at the 12th International Symposium on Pneumococci and Pneumococcal Diseases from 19 through 23 June 2022.

LimmaTech Biologics won the pitching contest at the AMR conference in Basel

LimmaTech Biologics will be attending the 6th AMR Conference from 7 through 8 April 2022.

LimmaTech Biologics will be attending the International Congenital CMV Conference from 28 March through 1 April 2022.